New lung cancer drug turns body into a tumour-fighting weapon
1 June 2015
Commenting on the trial results of Nivolumab, an immune-boosting
drug, Dr Martin Forster (UCL Research Department of Oncology) said: "These
drugs will be a paradigm shift in how we treat lung cancer".
Close
